← Back to PYXS

Pyxis Oncology, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 03/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Sep 2024Filed 03/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 14/08/2025
$2.8$16
−$25−$23−$22−$18−$21−$21−$17−$3.3
−$0.40−$0.37−$0.35−$0.30−$0.35−$0.35−$0.29−$0.06
6463636261616051

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.